Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers

NCT02180490 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: UHAC 62 XX tablet
DRUG: UHAC 62 XX capsule

Sponsor

Boehringer Ingelheim